share_log

CRISPR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director High Katherine A

CRISPR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director High Katherine A

CRISPR Therapeutics | 4：持股變動聲明-董事 High Katherine A
美股sec公告 ·  05/31 16:21
Moomoo AI 已提取核心訊息
Katherine A. High, associated with CRISPR Therapeutics (CRSP.US), was involved in a transaction on 05/30/2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of the shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. Investors are advised to await further information to fully understand the impact of this event on their investment decisions regarding CRISPR Therapeutics stock.
Katherine A. High, associated with CRISPR Therapeutics (CRSP.US), was involved in a transaction on 05/30/2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of the shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. Investors are advised to await further information to fully understand the impact of this event on their investment decisions regarding CRISPR Therapeutics stock.
與CRISPR Therapeutics（CRSP.US）相關的凱瑟琳·海於2024年5月30日參與了一筆交易。公告中未披露交易的具體細節，包括行動類型、狀態、所涉股份數量、股票性質、交易價格和交易後的持股情況。建議投資者等待進一步的信息，以充分了解此事件對他們有關CRISPR Therapeutics股票的投資決策的影響。
與CRISPR Therapeutics（CRSP.US）相關的凱瑟琳·海於2024年5月30日參與了一筆交易。公告中未披露交易的具體細節，包括行動類型、狀態、所涉股份數量、股票性質、交易價格和交易後的持股情況。建議投資者等待進一步的信息，以充分了解此事件對他們有關CRISPR Therapeutics股票的投資決策的影響。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息